Document is current
Any future updates will be listed below
-
Authors
Ilha, Mariana
Sehgal, Ratika
Matilainen, Johanna
Rilla, Kirsi
Kaminska, Dorota
Gandhi, Shrey
Männistö, Ville
Ling, Charlotte
Romeo, Stefano
Pajukanta, Päivi
Pirinen, Eija
Virtanen, Kirsi A.
Pietiläinen, Kirsi H.
Vaittinen, Maija https://orcid.org/0000-0002-7423-557X
Pihlajamäki, Jussi
-
Funding
Funding for this research was provided by:
Health from Science (404030)
GenomMed Doctoral Programme
Horizon 2020 Framework Programme of the European Union (740264)
Academy of Finland (337120, 337120, 316458, 335445, 314455, 336449, 324494)
Jane and Aatos Erkko Foundation
Finnish Medical Foundation
Swedish Research Council
Region Skåne
Novo Nordisk Foundation (NNF20OC0060547, NNF17OC0027232, NNF10OC1013354)
EFSD
The Swedish Diabetes Foundation
EXODIAB
Swedish Foundation for the Strategic Research (Dnr IRC15-0067)
National Institutes of Health (R01HL170604, R01DK132775, R01HG010505)
Academy of Finland (314456, 335446, 335443, 314383, 272376, 266286, 138006, 314454, 335444)
Gyllenberg Foundation
Finnish Diabetes Research Foundation
University of Helsinki
Government Research Funds
Helsinki University Hospital
Kuopio University Hospital (EVO/VTR grants 2005–2019)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 16 February 2025
First Online: 1 March 2025
Change Date: 5 May 2025
Change Type: Update
Change Details: Three additional files were missing initially, and the published Supplementary Material included the marked revision of the file
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the Northern Savo Hospital District (54/2005, 104/2008, and 27/2010). Written consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing of interest with the contents of this article.
